Oct 21, 4:39 PM ET
Globe Life reported third quarter 2026 results with diluted net income of $4.62 per share, down from $4.73 a year earlier, while net operating income rose to $4.84 per share from $4.81. The company adjusted its full-year 2026 earnings guidance to $15.35 to $15.65 per share, citing high-severity claims at Evry and a Centers for Medicare and Medicaid Services claims processing delay at its United American General Agency division, and raised its 2026 share repurchase expectation to $725 million to $775 million.
- Q3 2026 net income was $361.1 million, compared with $387.8 million in Q3 2025; total premium revenue rose 7% to $1.31 billion.
- Health underwriting margin at United American was a loss of $6.4 million, reflecting an Evry underwriting loss of about $16 million and about $7 million of excess Medicare Supplement claims.
- Full-year 2026 earnings guidance was adjusted to $15.35 to $15.65 per share; the company estimates 2027 net operating income of $16.10 to $17.10 per share.
- During Q3 2026 the company repurchased 1.1 million shares for $185 million, and now expects 2026 repurchases of $725 million to $775 million, up from $670 million to $700 million.
Read the filing on SEC.gov ↗
Aug 7, 4:33 PM ET
Globe Life Inc. disclosed that director David A. Rodriguez retired from its Board of Directors effective immediately on August 4, 2026, citing personal reasons. The company said the departure was not due to any disagreement over its operations, policies or practices.
- Retirement effective immediately, as of August 4, 2026
- Reason given: personal reasons
- Company states no disagreement with management or the board on operations, policies or practices
- Disclosed in an 8-K filed August 7, 2026 under Item 5.02
Read the filing on SEC.gov ↗
Jul 22, 4:34 PM ET
Globe Life reported second quarter 2026 net income of $3.65 per diluted share, up from $3.05 a year earlier, and net operating income of $3.61 per share, up from $3.27. The company raised its full-year 2026 earnings guidance to $15.55 to $15.95 per share, an increase of $0.10 at the midpoint.
- Q2 2026 net income was $3.65 per diluted share vs. $3.05 in Q2 2025, up 20%.
- Q2 2026 net operating income was $3.61 per diluted share vs. $3.27, up 10%.
- Full-year 2026 EPS guidance raised to $15.55 to $15.95, up $0.10 at the midpoint.
- The company repurchased 1.1 million shares for $175 million during the quarter.
Read the filing on SEC.gov ↗
Jun 29, 5:26 PM ET
Globe Life signed a new $450 million term loan and a third amended credit agreement on June 26, 2026, with Wells Fargo replacing Bank of America as administrative agent. The filing shows the company extended its borrowing arrangements, with the term loan maturity moved to June 26, 2029 and the credit agreement maturity moved to June 26, 2031.
- Term loan principal increased from $250 million to $450 million, with maturity extended from August 15, 2027 to June 26, 2029.
- Credit agreement maturity extended from March 29, 2029 to June 26, 2031.
- Wells Fargo, National Association replaces Bank of America, N.A. as administrative agent under both agreements.
- The filing does not state the credit agreement's total commitment amount.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
